Source: GWASDB
| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MSH5-SAPCD1 readthrough (NMD candidate) | 0.760 | 0.423 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2008 | 2016 | |||||||||
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
disease | 0.100 | None | 1.000 | 2 | 10 | 2008 | 2014 | |||||||||
|
HLA complex group 9 | 0.700 | 0.500 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||||||
|
EHMT2 and SLC44A4 antisense RNA 1 | 0.780 | 0.462 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||||||
|
HLA complex P5 | 0.595 | 0.808 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||||||
|
major histocompatibility complex, class II, DR beta 9 (pseudogene) | 0.682 | 0.654 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||||||
|
major histocompatibility complex, class I, L (pseudogene) | 0.861 | 0.269 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||||||
|
long intergenic non-protein coding RNA 243 | 0.729 | 0.423 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||||||
|
tripartite motif containing 26B, pseudogene | 0.861 | 0.269 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||||||
|
HLA complex group 18 | 0.722 | 0.538 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||||||
|
HLA complex group 17 | 0.769 | 0.346 |
|
disease | 0.100 | None | 1.000 | 1 | 3 | 2014 | 2014 | |||||||||
|
heterogeneous nuclear ribonucleoprotein A1 pseudogene 1 | 0.931 | 0.154 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||||||
|
zinc finger and SCAN domain containing 26 | 0.931 | 0.115 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||||||
|
notch receptor 4 | 0.534 | 0.731 | 2.1E-23 |
|
disease | 0.110 | None | 1.000 | 1 | 2 | 2012 | 2014 | ||||||||
|
Ski2 like RNA helicase | 0.615 | 0.654 | 1.3E-22 |
|
disease | 0.120 | None | 1.000 | 1 | 2 | 2001 | 2014 | ||||||||
|
inositol 1,4,5-trisphosphate receptor type 3 | 0.555 | 0.808 | 2.6E-22 |
|
disease | 0.120 | None | 1.000 | 1 | 1 | 2008 | 2010 | ||||||||
|
butyrophilin subfamily 2 member A1 | 0.722 | 0.423 | 3.4E-21 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
complement C2 | 0.617 | 0.692 | 1.3E-16 |
|
disease | 0.450 | strong | 1.000 | 1 | 2 | 1976 | 2015 | ||||||||
|
testis expressed basic protein 1 | 0.638 | 0.692 | 1.5E-16 |
|
disease | 0.100 | None | 1.000 | 2 | 6 | 2008 | 2014 | ||||||||
|
complement factor B | 0.532 | 0.769 | 4.7E-16 |
|
disease | 0.400 | None | 1.000 | 2 | 1 | 2008 | 2015 | ||||||||
|
integrin subunit alpha X | 0.504 | 0.769 | 1.4E-15 |
|
disease | 0.150 | None | 1.000 | 1 | 2 | 2008 | 2019 | ||||||||
|
solute carrier family 44 member 4 | 0.678 | 0.615 | 1.0E-14 |
|
disease | 0.100 | None | 1.000 | 1 | 4 | 2014 | 2015 | ||||||||
|
BLK proto-oncogene, Src family tyrosine kinase | 0.585 | 0.769 | 8.3E-14 |
|
disease | 0.700 | None | 0.976 | 6 | 3 | 2008 | 2020 | ||||||||
|
UHRF1 binding protein 1 | 0.769 | 0.269 | 4.5E-13 |
|
disease | 0.430 | None | 0.857 | 1 | 3 | 2009 | 2019 | ||||||||
|
laminin subunit gamma 2 | 0.389 | 0.923 | 2.9E-12 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 |